Viral infections in the receptor of a solid organ transplantation;Infecciones virales en el receptor de un trasplante de organo solido

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 15, Issue SUPPL. 2, 1997, Pages 22-33

  Moreno, M Asunción ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HEPATITIS VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; ORGAN TRANSPLANTATION; REVIEW; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

HEPATITIS, VIRAL, HUMAN; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION; VIRUS ACTIVATION; VIRUS DISEASES;

EID: 0030975804     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (260)

1. Rubin RH. Infection in the organ transplant recipient. En: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host, 3a. ed. Nueva York: Plenum Press, 1994; 629-705.
2. Rubin RH, Tolkoff-Rubin NE. Viral infection in the renal transplant patient. Proc Eur Dial Transplant Assoc 1983; 19: 513-526.
3. O'Neill HJ, Shirodaria PV. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections. J Infect 1992; 24: 301-309.
4. Marker SC, Howard RJ, Simmons RL, Kalis JM, Connelly DP, Najarian JS et al. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants. Surgery 1981; 89 (6): 660-671.
5. Merlino C. Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients. G Batteriol Virol Immunol 1991; 84 (1-12): 41-52.
6. Baldwin WM, Henny FC, Van Gemert GW, Claas FHJ, Wested ML, Paul LC et al. Distinction between cytomegalovirus related graft loss and rejection. Transplant Proc 1985; 17: 2.600-2.602.
7. Battegay EJ, Mihatsch MJ, Mazzucchelli L, Zollinger HU, Gudat F et al. Cytomegalovirus and kidney. Clin Nephrol 1988; 30 (5): 239-247.
8. Tenschert W, Huland H. Cytomcgalovirus diseases following allogenic kidney transplantation. Med Klin 1992; 87 (Supl 1P): 43-48.
9. Pouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged A, Tardy JC, Bosshard S et al. Cytomegalovirus infection: an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 1993; 55 (4): 851-857.
10. Rubin RH, Tolkoff-Rubin NE. Viral infection in the renal transplant patient. Proc Eur Dial Transplant Assoc 1983; 19: 513-526.
11. Borisch B, Fey MF, Tobler A, Burki K, Gatter KC, Wainscoat JS. Large cell anaplastic lymphomas in the immunocompromised host. Verh Dtsh Ges Pathol 1991; 75: 171-174.
12. Borisch B, Gatter KC, Tobler A, Theilkas L, Bunch D, Wainscoat JS et al. Am J Clin Pathol 1992; 98: 312-318.
13. Kumar S, Kumar D, Kingma DW, Jaffe ES. Epstein Barr virus associated T-cell lymphoma in a renal transplant patient. Am J Surg Pathol 1993; 17: 1.046-1.053.
14. Chanez P, Mourad G, Aubas P, Guillot B, Gobard P, Mion C et al. Kaposi's sarcoma of the bronchial tree in a renal transplant recipient. Respiration 1988; 53 (4): 259-261.
15. Siegal B, Levinton-Kriss S, Schiffer A, Sayar J, Engelberg I, Vonsover A et al. Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer 1990; 65 (3): 492-498.
16. Bradford CR, Hoffman HT, Wolf GT, Carey TE, Baker SR, McClatchey KD. Squamous carcinoma of the head and neck in organ transplant recipients: possible role of oncogenic viruses. Laryngoscope 1990; 100 (2 Pt 1): 190-194.
17. Montagnac R, Hannart V, Rosnet D, Schillinger F, Casola M. Human papilomavirus, cervical intraepithelial cancer and immunosuppression. Two cases in renal transplant recipients. Rev Fr Gynecol Obstet 1992; 87: 61-64.
18. Viac J, Chardonnet Y, Euvrard S, Chignol MC, Thivolet J. Langerhans cells, inflamation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipient. J Dermatol 1992; 19: 67-77.
19. Bavink JN, Gissman L, Class FH, Van der Woude FJ, Persijin GG, Ther Schegget J et al. Relation between skin cancer, humoral responses to human papillomavirus, and HLA class II molecules in renal transplant recipients. J Immunol 1993; 151 (3): 1.579-1.586.
20. Euvrard S, Chardonnet Y, Pouteil-Noble C, Kanitakis J, Chignol MC, Thivolet J et al. Association of skin malignancies with various and multiple carcinogenic and non carcinogenic human papillomavirus in renal transplant recipients. Cancer 1993; 72: 2.198-2.206.
21. Drew WL, Mills J, Hauer LB et al. Declining prevalence of Kaposi's sarcoma homosexual AIDS patients paralleled by fall in cytomegalovirus transmission. Lancet 1988; 1 (8575-6): 66.
22. Mintz L, Drew WL, Miner RC et al. Cytomegalovirus infections in homosexual men: an epidemiological study. Ann Intern Med 1983; 99: 326-329.
23. Cohen JI, Corey GR. Cytomegalovirus infection in the normal host. Medicine 1985; 64: 100-114.
24. Chretien JH, McGinniss CG, Muller A. Venereal causes of cytomegalovirus mononucleosis. JAMA 1977; 238: 1.644-1.645.
25. Rubin RH. Infection in the renal and liver transplant patient. En: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host, 2a. ed. Nueva York: Plenum Publishing Co., 1988; 557.
26. Glenn J. Cytomegalovirus infection following renal transplantation. Rev Infect Dis 1931; 3: 1.151-1.178.
27. Peterson PK, Balfour HH, Marker SC et al. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) 1980; 59: 283-300.
28. Rubin RH, Tolkoff-Rubin NE, Oliver D et el. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985; 40: 243.
29. Farrugia E, Schwab TR. Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc 1992; 67: 879-890.
30. Kaden J, Zenker S, Eichler C et al. Risk of CMV infection and illness after kidney transplantation. Allerg Immunol (Leipz) 1991; 37: 47-58.
31. Suwansirikul S, Rao N, Dowling JN et al. Primary and secondary cytomegalovirus infection. Arch Intern Med 1977; 37: 1.026-1.029.
32. Grundy JE, Super M, Lui SF et al. Donor strains of cytomegalovirus in renal-transplant recipients. N Engl J Med 1986; 315 (19): 1.229.
33. Grundy JE, Super M, Lui S et al. The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney. Transplant Proc 1987; 19: 2.126-2.128.
34. Grundy JE. Virologic and pathogenetic aspects of cytomegalovirus infection. Rev Infect Dis 1990; 12 (Supl 7P): 711-719.
35. Polak R, Barber PL, Mozes MJF et al. Cytomegalovirus as a risk factor in living-related renal transplantation. Ann Surg 1987; 205: 302-304.
36. Chou SW. Acquisition of donor strains of cytomegalovirus by renal-transplant patients. N Engl J Med 1986; 314: 1.418-1.423.
37. Kanesaki T, Baba K, Tanaka K et al. Characterization of cytomegalovirus isolates recovered during repeated infection in renal transplant recipients. J Med Virol 1989; 28 (3): 140-143.
38. Chou S, Kim DY, Norman KJ. Transmission of cytomegalovirus by pretransplant leukocyte transfusions in renal transplant candidates. J Infect Dis 1987; 155: 565-567.
39. Ho M, Suwansirikul S, Dowling JN et al. The transplanted kidney as a sour-ce of cytomegalovirus infection. N Engl J Med 1975; 293:1.109-1.112.
40. Van den Berg AP, Van Son WJ, Janssen RA et al. Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes. J Infect Dis 1992; 166(6): 1.228-1.235.
41. Brouillette DE, Alexander J, Yoo YK et al. T-cell populations in liver and renal transplant recipients with infectious esophagitis. Dig Di Sci 1989; 34 (1): 92-96.
42. Pass RF, Whitley RJ, Whelchel JD et al. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis 1979; 140: 487.
43. Betts RF, Freeman RB, Douglas RG et al. Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child 1977; 131: 759-763.
44. Matulis WS, Cokeley G, Matulis M et al. Renal transplant and cytomegalovirus infection: experience in a community hospital program. W V Med J 1992; 88: 454-456.
45. Metsellar HJ, Weimar W. Cytomegalovirus infection and renal transplantation. J Antimicrob Chemother 1989; 23 (Supl EP): 37-47.
46. Conlon PJ Jr, Carmody M, Donohoe J et al. Cytomegalovirus infection as a complication of OKT3 therapy in kidney transplant recipients. Ir J Med Sci 1992; 161 (11): 630-631.
47. Bailey TC, Powderly WG, Storch GA et al. Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis. Am J Kidney Dis 1993; 21: 196-201.
48. Andreu J, Campistol JM, Oppenheimer F et al. Improved results in elderly renal transplants without prophylactic steroids. Clin Transplantation 1991; 5: 3-6.
49. Canadian Multicenter Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1986; 314: 1.219-1.225.
50. Marker SC, Howard RJ, Simmons RL et al. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants. Surgery 1981; 89 (6): 660-671.
51. Merlino C, Angeretti A, Segoloni GP et al. CMV-specific polymeric and monomeric IgA antibodies in serum of renal transplant patients. Panminerva Med 1991; 33: 173-179.
52. Baldwin WM, Henny FC, Van Gemert GW et al. Distinction between cytomegalovirus related graft loss and rejection. Transplant Proc 1985; 17: 2.600-2.602.
53. Tenschert W, Huland H. Cytomegalovirus diseases following allogenic kidney transplantation. Med Klin 1992; 87 (Supl 1): 43-48.
54. Pouteil-Noble C, Ecochard R, Landrivon G et al. Cytomegalovirus infection: an etiological for rejection? A prospective study in 242 renal transplant patients. Transplantation 1993; 55 (4): 851-857.
55. Bosch FH, Hoitsma AJ, Janssen HP et al. Cytomegalovirus infection and disease in renal transplant patients treated cyclosporin. A prospective study. Transplant Int 1989; 2 (2): 92-95.
56. Dittmer R, Harfmann P, Busch R et al. CMV Infection and vascular rejection in renal transplant patients. Transplant Proc 1989; 21 (4): 3.600-3.601.
57. Spencer ES, Jepsen FL. Glomerulopathy in renal allografts from patients with and without active cytomegalovirus infection. Dan Med Bull 1989; 36 (3): 300-301.
58. Battegay EJ, Mihatsch MJ, Mazzucchelli L et al. Cytomegalovirus and kidney. Clin Nephrol 1988; 30 (5): 239-247.
59. Richardson WP, Colvin RB, Cheeseman SH et al. Glomerulopaty associated with cytomegalovirus viremia in renal allografts. N Engl J Med 1981; 305: 57-63.
60. Rubin RH, Cosimi AB, Tolkoff-Rubin NE et al. Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation 1977; 24: 458-464.
61. Calhoon JH, Nichols L, Davis R et al. Single lung transplantation: factors in postoperative cytomegalovirus infection. J Thoracic Cardiovasc Surg 1992; 103: 21-25.
62. Ando H, Shiramizu T, Hisanou R. Dilated cardiomyopathy caused by cytomegalovirus infection in a renal transplant recipient. Jpn Heart J 1992; 33 (3): 409-412.
63. Gonwa TA, Capehart JE, Pilcher JW et al. Cytomegalovirus myocarditis as a cause of cardiac dysfunction in a heart transplant recipient. Transplantation 1989; 47: 197-199.
64. Millett R, Tomita T, Marshall HE et al. Cytomegalovirus endomyocarditis in a transplanted heart: a case report with in situ hybridization. Arch Pathol Lab Med 1991; 115: 511-515.
65. Legendre C, Mourad G, Baldet P et al. Acute cytomegalovirus glomerulonephitis in a renal transplant patient. Nephrologie 1988; 9 (1): 33-35.
66. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12 (Supl 7): 754-766.
67. Deny P, Debure A, Agut H et al. Detection of human cytomegalovirus DNA in liver biopsies from patients with cytomegalovirus-related liver disease. Res Virol 1989; 140 (4): 361-372.
68. Aafedt BC, Halvorsen RA, Tylen U et al. Cytomegalovirus pneumonia: computed tomography findings. J Canad Assoc Radiol 1990; 41: 276-280.
69. Mayoral JL, Loeffler CM, Fasola CG et al. Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch Surg 1991; 126: 202-206.
70. Jones AC, Freedman PD, Phelan JA et al. Cytomegalovirus infections of the oral cavity. Oral Surg Oral Med Oral Pathol 1993; 75: 76-85.
71. Jacobson MA, Mills J. Cytomegalovirus infection. Clinic Chest Med 1988; 9: 443-448.
72. Bigio EH, Haque AK. Disseminated cytomegalovirus infection presenting with acalculous cholecystitis and acute pancreatitis. Arch Pathol Lab Med 1989; 113 (11): 1.287-1.289.
73. Bamborschke S, Wullen T, Huber M et al. Early diagnosis and successful treatment of acute cytomegalovirus encephalitis in a renal transplant recipient. J Neurol 1992; 239: 205-208.
74. Richert JR, Potolicchio S, Garagusi VF et al. Cytomegalovirus encephalitis associated with episodic neurologic deficits and OKT-8+pleocytosis. Neurology 1987; 37: 149-152.
75. Singh N, Yu VL, Gayowski T. Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine 1994; 73: 110-118.
76. Spitzer PG, Tarsy D, Eliopoulos GM. Acute transverse myelitis during disseminated cytomegalovirus in a renal transplant recipient. Transplantation 1987; 44: 151-153.
77. Lloveras JJ, Larue V, Delisle MB et al. Syndrome de Guillain-Barré associé à une infection à cytomegalovirus après transplantation rénale. Presse Med 1994; 23: 976-978.
78. Quinlan MF, Salmon JF. Ophthalmic complications after heart transplantation. J Heart Lung Transplant 1993; 12: 252-255.
79. Bloom JN, Palestine AG. The diagnosis of cytomegalovirus retinitis. Ann Intern Med 1988; 109: 963-969.
80. Smit WM, Wagemans MAJ, Jansen CL et al. Acute retinal necrosis in a renal allograft recipient. An unusual manifestation of cytomegalovirus infection. Trasplantation 1993; 55: 219-221.
81. Pillay D, Ali ȦA, Liu SF et al. The prognostic significance of positive CMV cultures during surveillance of renal transplant recipients. Transplantation 1993; 56 (1): 103-108.
82. McCarthy JM, McLoughlin MG, Shackleton CR et al. Cytomegalovirus epidymitis following renal transplantation. J Urol 1991; 146: 417-419.
83. Frank TS, Li Volsi VA, Conor AM. Cytomegalovirus infection of the thyroid in immunocompromised adults. Yale J Biol Med 1987; 60: 1-8.
84. Peterson P, Stahl-Bayliss CM. Cytomegalovirus thrombophlebitis after successful DHPG therapy. Ann Intern Med 1987; 106: 632-633.
85. Martínez-Marcos F, Cisneros JM, Gentil M et al. Prospective study of renal transplant infections in 50 consecutive patients. Eur J Clin Microbiol Infect Dis 1994; 13: 1.023-1.028.
86. Lumbreras C, Otero JR, Aguado JM et al. Estudio prospectivo de la infección por citomegalovirus en receptores de trasplante hepático. Med Clin (Barc) 1992; 99: 401-405.
87. Simmons RL, Matas AJ, Rattazzi LC et al. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 1977; 82: 537-546.
88. O'Neill HJ, Shirodaria PV. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections. J Infect 1992; 24: 301-309.
89. Mackowiak PA, Goggans M, Torres W et al. Relationship between cytomegalovirus and colonization of the oropharynx by gram negative bacilli following renal transplantation. Epidemiol Infect 1991; 107: 411-420.
90. Rubin RH, Tolkoff-Rubin NE. Opportunistic infections in renal allograft recipients. Transplant Proc 1988; 20 (Supl 8): 12-18.
91. Lui SF, Sweny P, Grundy JE et al. The clinical application of a rapid diagnostic test for the detection of cytomegalovirus infection in renal transplant recipients. Transplant Proc 1987; 19: 2.129-2.130.
92. Klevjer-Anderson P. Diagnostic significance of CMV serology. Clin Microbiol Newslett 1987; 9: 36-38.
93. Gleaves CA. Recent developments in laboratory methods for the rapid detection of cytomegalovirus. Clin Microbiol Newslett 1986; 8: 168.
94. Agha SA, Mahmoud LA, Archard LC et al. Early diagnosis of cytomegalovirus infection in renal transplant and dialysis patients by DNA-DNA hybridisation assay. J Med Virol 1989; 27 (3): 252-257.
95. Debure A, Celton JL, Cartron J et al. Granulocyte-associated immunoglobulins in renal transplant recipients with cytomegalovirus infection. Lancet 1988; 2: 1.338-1.340.
96. Van der Bij W, Schirm J, Torensma R et al. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol 1988; 26: 2.531-2.535.
97. Van der Berg AP, Van der Bij W, Van Son WJ et al. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation. A report of 130 consecutive patients. Transplantation 1989; 48: 991-995.
98. Freymuth F, Petitjean J, Hurault de Ligny B et al. Leukocytic cytomegalic antigen. A new diagnostic method of cytomegalovirus infection after transplantation. Presse Med 1992; 21 (36): 1.710-1.713.
99. Paya CV. Fungal infections in solid organ transplantation. Clin Infect Dis 1993; 16: 677-688.
100. Fisher L, Rautenberg P, Bienengraber H et al. Antigenemia, immunobloting, and enzyme immunoassay for early diagnosis of cytomegalovirus infection in renal transplant recipients. Transpl Int 1993; 6 (4): 201-205.
101. Bein G, Bitsch A, Hoyer J et al. A longitudinal prospective study of cytomegalovirus pp65 antigenemia renal transplant recipients. Transpl Int 1993; 6 (4): 185-190.
102. Eichler C, Kaden J, Strobelt V et al. Detection of cytomegalovirus using monoclonal antibodies in aspiration biopsy material kidney transplants. Z Urol Nephrol 1989; 82 (1): 13-20.
103. Cheeseman SH, Stewart JA, Winkle S et al. Cytomegalovirus excretion 2-14 years after renal transplantation. Transplant Proc 1979; 11: 71-74.
104. Olive DM, Al Mufti S, Simsek M et al. Direct detection of human cytomegalovirus in urine specimens from renal transplant patients following polymerase chain reaction amplification. J Med Virol 1989; 29 (4): 232-237.
105. Bryting M, Xu W, Wahren B et al. Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Microbiol 1992; 30 (8): 1.937-1.941.
106. Lorino G, Lilli D, Dicuonzo G et al. Cytomegalovirus infection follow-up in renal transplant patients by the polymerase chain reaction. Transpl Proc 1993; 25 (3): 2.280-2.281.
107. Cinque P, Vago L, Brytting M et al. Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis 1992; 166: 1.408-1.411.
108. Wolf DG, Spector SA. Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J Infect Dis 1992; 166: 1.412-1.415.
109. Gozlan J, Salord JM, Rullet E et al. Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis 1992; 166: 1.416-1.421.
110. Dolan J, Briggs JD, Clements GB. Antibodies to cytomegalovirus in renal allograft recipients: correlation with isolation of virus. J Clin Pathol 1989; 42 (10): 1.070-1.077.
111. McMahon CA, Dock NL, Lentz EB et al. Detection of cytomegalovirus-specific IGM in renal transplant. J Clin Lab Anal 1989; 3 (6): 350-354.
112. Weber B, Braun W, Tyralla B et al. Human cytomegalovirus (HCMV) specific immunoglobulin E as a serologic marker for HCMV infection in immunocompromised patients. Clin Invest 1992; 70 (6): 497-502.
113. Hamann A, Doerr HW. IgG subclass-specific antibodies to human cytomegalovirus (HCMV)-induced early antigens. Med Microbiol Immunol (Berl) 1991; 180: 193-204.
114. Mathiesen T, Brattstrom C, Anderson J et al. Immunoglobulin G, subclasses and lymphocyte stimulatory responses to cytomegalovirus in transplant patients with primary cytomegalovirus infections. J Med Virol 1992; 36: 65-69.
115. Bibbo M. Comprehensive cytopathology. Filadelfia: WB Sounders, 1991.
116. Koss LG. Diagnostic cytology and its histopathological bases. Filadelfia: JP Lippincott 1992; 734.
117. Nobuzo I, Masaomi S, Chikao Y et al. Detection of cytomegalovirus DNA in pulmonary specimens: confirmation by in situ hibridization in two cases. Diagn Cytopah 1992; 8: 357-360.
118. Escudier E, Fleury J, Cordonnier C et al. Large granular lymphocytes in bronchoalveolar lavage fluids from immunocompromised patients with cytomegalovirus pneumonitis. Am J Clin Pathol 1986; 86 (5): 645-651.
119. Gal AA, Klatt EC, Koss MN et al. The effectiveness of bronchoscopy in the diagnosis of Pneumocystis carinii and cytomegalovirus pulmonary infection in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1987; 111: 238-241.
120. Shibata D, Martin WJ, Appleman MD et al. Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis 1988; 158(6): 1.185-1.192.
121. Hilborne LH, Nieberg RK, Cheng L et al. Direct in situ hybridization for rapid detection of cytomegalovirus in bronchoalveolar lavage. Am J Clin Pathol 1987; 87: 766-769.
122. Emanuel D, Peppard J, Stover D et al. Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies. Ann Intern Med 1986; 104: 476-481.
123. Springmeyer SC, Hackman RC, Holle R et al. Use of bronchoalveolar lavage to diagnose acute diffuse pneumonia in the immunocompromised host. J Infect Dis 1986; 154: 605-610.
124. De Fine LA, Saleba KP, Gibson BB et al. Cytologie evaluation of bronchoalveolar lavage specimens in immunosupressed patients with suspected opportunistic infections. Acta Cytol 1987; 31: 235-242.
125. Martin WJ, Smith TF, Sanderson DR et al. Role of bronchoalveolar lavage in the assessment of opportunistic pulmonary infections: utility and complications. Mayo Clin Proc 1987; 62: 549-631.
126. Jain N, Manic K, Frabbe WJ. Cytological diagnosis frorm bronchial brushing materials. Acta Cytol 1973; 17: 467-468.
127. Nash G. Respiratory system. En: Nash G, Said JW, eds. Pathology of AIDS and HIV infection. Filadelfia: WB Saunders, 1992; 71-75.
128. Milburn HJ, Grundy JE, du Bois RM et al. Is the measurement of virus-specific antibody in the lungs of transplant recipients with cytomegalovirus pneumonitis of diagnostic or pronostic value? J Med Virol 1988; 26 (2): 197-206.
129. Roboy SS, Gage WR, Kuhajda FP. Comparison of immunoperoxidase and DNA in situ hybridization techniques in the diagnosis of cytomegalovirus colitis. Am J Clin Pathol 1988; 89: 666-671.
130. Vinters HV, Kwok MK, Ho HW et al. Cytomegalovirus in the nervous system of patients with the acquired immunodeficiency syndrome. Brain 1989; 112: 245-268.
131. Kalaylian RC., Cohen ML, Bonomo RA et al. Cytomegalovirus ventriculo-encephalitis in AIDS. A syndrome with distinct clinical and pathologic features. Medicine 1993; 72: 67-77.
132. Achim CL, Nagra RM, Wang R et al. Detection of cytomegalovirus in cerebrospinal fluid autopsy specimens from AIDS patients. J Infect Dis 1994; 169: 623-627.
133. Lautenschlager I, Ahonen J, Eklund B, Hockerstedt K, Salmela K, Isoniemi H et al. Hyperimmune globulin therapy of clinical cytomegalovirus infection in renal allograft recipients. Scand J Infect Dis 1989; 21: 139-143.
134. Legendre C, Ducloux D, Ferroni A, Chkoff N, Valette C, Geffrier C et al. Acyclovir in preventing cytomegalovirus infection in kidney transplant recpients: a case controlled study. Transplant Proc. 1993; 25: 1.431-1.433.
135. Erice A, Jordan MC, Chace BA, Flechtter C, Chinnock BJ, Balfour HH. Gancyclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised host. JAMA 1987; 257: 3.082.
136. Laskin OL, Cedeberg DM, Millis J, Eron LJ, Midvan D, Spector SA. Gancyclovir for the treatment and supression of serious infections caused by cytomegalovirus. Am J Med 1987; 83: 201.
137. Snydman DR. Gancyclovir therapy for cytomegalovirus disease associated with renal transplant. Rev Infect Dis 1988; 10: S554.
138. Crumpacker C, Marlowe S, Zhang JL, Abrams S, Watkins P. Treatment of cytomegalovirus pneumoniae. Rev Infect Dis 1988; 10: 538.
139. Paya CV, Hermans PE, Smith TF. Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation 1988; 46: 229-234.
140. Nicholson ML, Flower AJ, Simpson A, Donnelly PK, Veitch PS, Bell PR. Ganciclovir for severe cytomegalovirus infection in transplant recipients. Lancet 1988; 2: 1.501-1.502.
141. Nicholson ML, Veitch PS, Donnelly PK, Flower AJ, Bell PR. Treatment of renal transplant associated cytomegalovirus infection with ganciclovir. Transplant Proc 1990; 22: 1.811-1.812.
142. Winston DJ, Ho WG, Bartony K. Gancyclovir therapy for cytomegalovirus infections in recipientts of bone-marrow recipients and other immunosuppressed patients. Rev Infect Dis 1988; 10: S547.
143. Guerin C, Pozzetto B, Broyet C, Gaudin O, Berthoux F. Gancyclovir therapy of symptomatic cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant 1989; 4: 906-910.
144. Lang P, Buisson C, Rostoker G, Ben Maadi A, Fruchaud G, Deforge L et al. DIIPG treatment of kidney transplant recipients with severe CMV infection. Transplant Proc 1989; 21: 2.084-2.086.
145. Rondeau E, Farquet C, Ruedin P, Fries D, Sraer JD. Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients. Transplant Proc 1990; 22: 1.813-1.814.
146. Rondeau E, Farquet C, Fries D, Sraer JD. Treatment of cytomegalovirus infections with ganciclovir in kidney transplant recipients. Clinical and pharmacokinetic study. Presse Med 1991; 20: 2.030-2.032.
147. Nevins TE, Dunn DL. Use of ganciclovir for cytomegalovirus infection. J Am Soc Nephrol 1992; 2: S270-S273.
148. Jordan ML, Hrebinko RL, Jr., Dummer JS, Hickey DP, Saphiro R, Vivas CA et al. Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol 1992; 148: 1.388-1.392.
149. Ringden O, Lonnqvist B, Paulin T, Ahlmen J, Klintmalm G, Wahren B et al Pharmacokinetics safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. J Antimicrob Chemother 1986; 17: 373-387.
150. Van der Berg AP, Tegzess AM, Scholten-Sampson A, Schirm J, Van der Giessen M, The TH et al. Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation. Transpl Int 1992; 5: 101-106.
151. Van der Berg AP, Van Son WJ, Haagsman EB, Klompmaker U, Tegzees AM, Schiirm J et al. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid organ transplant rexcipients. Transplantation 1993; 55: 847-851.
152. Bitsch A, Kirchner H, Dennin R, Hoyer J, Fricke L, Steinhoff J et al. The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection. Transplantation, 1993; 56: 108-113.
153. Greenberg MS, Friedman H, Cohen SG, Ho SH, Laster L, Starr S. A comparative study of Herpes Simplex infections in renal transplant and leukemic patients. J Infect Dis 1987; 156: 280.
154. Arora KK, Karalakulasingam R, Raff MJ, Martin DG. Cutaneous herpesvirus hominis (type 2) infection after renal transplantation. JAMA 1974; 230: 1.174.
155. Dummer JS, Armstrong J, Somers J, Kusne S, Carpenter BJ, Rosenthal JT et al. Transmission of infection with herpes simplex virus by renal transplantation. J Infect Dis 1987; 155: 202.
156. Pass RF, Long WK, Whitley RJ, Soong SJ, Diethelm AG, Reynolds DW et al. Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney. J Infect Dis 1978; 137: 556.
157. Pass RF, Whitley RJ, Diethelm AG, Whelchel JD, Reynolds DW, Alford CA. Outcome of renal transplantation in patients with primary cytomegalovirus infection. Transplant Proc 1979; 11: 1.288.
158. Spencer ES, Fjeldborg O, Mordhorst CH. Herpes simplex infection in relation to kidney allograft survival. Dan Med Bull 1988; 35 (5): 499-500.
159. Bader C, Crumpacker CS, Schnipper LE, Ransil B, Clark JE, Arndt K et al. The natural history of recurrent facial-oral infection with herpes simplex virus. J Infect Dis 1978; 138: 897.
160. Silvert PL, Martz LR, Christiansen K, Saker BM, Richardson M. Herpes simplex virus intersticial nephritis in a renal allograft. Clin Nephrol 1990; 33 (6): 264-268.
161. Morris DJ, Littler E, Arrand JR, Jordan D, Mallick NP, Hohnson RW. Human herpesvirus 6 infection in renal-transplant recipients. N Engl J Med 1989; 320 (23): 1.560-1.561.
162. Merlino C, Sinesi F, Messina M, Giacchino F, Negro Ponzi A. Infection by human herpesvirus type 6 (HHV.6) and renal transplantation. Minerva Urol Nefrol 1992; 44 (2): 147-153.
163. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yakazi T, Ono Y et al. A prospective study of human herpesvirus-6 infection in renal transplantation. Transplant 1992; 54 (5): 879-883.
164. Kikuta H, Itami N, Matsumoto S, Chikaraishi T, Togashi M. Frequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from kidney transplant patients. J Infect Dis 1991; 163: 925.
165. Naragi S, Jackson GG, Jonasson O, Yamashiroya HM. Prospectiv study of prevalence, incidence, and source of herpesvirus infections in patiens with renal allografts. J Infect Dis 1977; 136: 531.
166. Luby JP, Ramírez-Ronda D, Rinner S, Hull A, Vergne-Marini P. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis 1977; 135: 659.
167. Peterson LR, Ferguson RM. Fatal central nervous system infection with varicella-zoster virus in renal transplant recipients. Transplantation 1984; 37 (4): 366-368.
168. Lynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipients. Pediatrics 1992; 90: 216-220.
169. Bradley JR, Wreghitt TG, Evans DB. Chickenpox in adult renal transplant recipients. Nephorl Dial Transplant 1987; 1(4): 242-245.
170. Straus SE. The management of varicella and zoster infections. Infect Dis Clin North Am 1987; 1: 367.
171. McKendrick MW, McGill JI, White JE, Wood MJ. Oral acyclovir in acute herpes zoster. Br Med J 1986; 293: 1.529.
172. Balfour HH, Bean B, Laskin OL. Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 1983; 308: 1.448.
173. Shepp DH, Dandliker PS, Meyers KJ. Treatment of varicella-zoster virus infections in severely immunocompromised patients. A randomized comparison of Acyclovir and Vidarabine. N Engl J Med 1986; 314: 208.
174. Strauch B, Andrews LL, Siegel N, Miller G. Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet 1974; 1: 234.
175. Naragi S, Jonasson O, Jackson GG, Yamashiroya HM. Clinical manifestations of infections with herpesviruses after kidney transplantation. Ann Surg 1978; 188: 234.
176. Marker SC, Ascher NL, Kalis JM, Simmons RL, Najarian JS, Balfour HH. Epstein-Barr virus antibody response and clinical illness in renal transplant recipients. Surgery 1979; 85: 433.
177. Hanto DW, Sakamoto K, Purtilo DT, Simmons RL, Najarian JS. The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Surgery 1981; 90: 204.
178. Cheeseman SH, Henle W, Rubin RH, Tolkoff-Rubin NE, Cosimi B, Cantell K et al. Epstein-Barr virus infection in renal transplant recipients. Ann Intern Med 1980; 93: 39.
179. Pedneault L, Katz BZ, Miller G. Detection of Epstein-Barr virus in the brain by the polymerase chain reaction. Ann Neurol 1992; 32 (2): 184-192.
180. Hin P, Rufli T, Rudlinger R, Cathomas G, Huser B, Podvinec M et al. Oral hairy leukoplasia in a HIV-negative renal transplant patient: a marker for immunossupression? Dermatologica 1988; 177: 126-128.
181. Borisch B, Hennig I, Horber F, Burki K, Laissue J. Enteropathy associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement. Virchows Arch A Pathol Anat Histopathol 1992; 421 (5): 443-447.
182. Borisch B, Fey MF, Tobler A, Burki K, Gatter KC, Wainscoat JS. Large cell anaplastic lymphomas in the immunocompromised host. Verh Dtsh Ges Pathol 1991; 75: 171-174.
183. Kumar S, Kumar D, Kingma DW, Jaffe ES. Epstein-Barr virus-associated T-cell lymphoma in a renal transplant patient. Am J Surg Pathol 1993; 17 (10): 1.046-1.053.
184. Drut R, Drut RM, EBV-associated Kaposi's sarcoma in a pediatric renal transplant recipient. Pediatr Pathol 1994; 14 (5): 863-872.
185. Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrrell DL. Quantitative oropharingeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to inimunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J Infect Dis 1992; 166 (5): 986-994.
186. Lagar DJ, Slager DD, Burgart LJ. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy speciments using the polumerase chain reaction. Report of a patient with a postransplant lymphoproliferative disorder. Arch Pathol Lab Med 1993; 117 (3): 308-312.
187. Cohen JI, Epstein-Barr virus lymphropliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) 1991; 70: 137-160.
188. Shiong YS, Lian JD, Lin CY, Shu KH, Lu YS, Chou G. Epstein-Barr virus associated T-cell lymphoma of the maxillary sinus in a renal transplant recipient. Transplant Proc 1992; 24 (5): 1.929-1.931.
189. Montone KT, Friedman H, Hodinka RL, Hicks DG, Kant JA, Tomakewski JE. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder. Med Pathol 1992; 5 (3): 292-302.
190. Diaz-Mitoma F, Preiksaitis JK, Leung WC, Tyrrell DL. DNA-DNA dot hybridization to detect Epstein-Barr virus in throat washings. J Infect Dis 1987; 155 (2): 297-303.
191. Rostaing L, Icart J, Durand D, Henry S, Lloveras JJ, Diddier J et al. Clinical outcome of Epstein-Barr viremia in transplant patients. Transplant Proc 1993; 25 (3): 2.286-2.287.
192. Mozes MF, Ascher NI, Balfour HH, Simmons RL, Najarian JS. Jaundice after renal allotransplantation. Ann Surg 1978; 188: 783.
193. Ware AJ, Luby JP, Hollinger B, Eigengrodt EH, Cuthbert JA, Atkins CR et al. Etiology of liver disease in renal-transplant patients. Ann Intern med 1979; 91: 364.
194. Sopko J, Anuras S. Liver disease in renal transplant recipients. Am J Med 1978; 64: 139.
195. Scott D, Mijch A, Lucas CR, Marshall V, Thomson N, Atkins R. Hepatitis B and renal transplantation. Transplant Proc 1987; 19: 2.159.
196. Parfrey PS, Forbes RDC, Hutchinson TA, Kenick S, Farge D, Dauphinee WD et al. The impact of renal transplantation of the course of hepatitis B liver disease. Transplantation 1985; 39: 610.
197. Weir MR, Kirkman RL, Strom TB, Tilney NL. Liver disease in recipients of long-functioning renal allografts. Kidney Int 1985; 28: 839.
198. Alvarez Chiva V, Carreño V, Plaza JJ, Mora I, Hernando L. Infección por virus de hepatitis en el trasplante renal. Estudio prospectivo. Nefrología 1984; 4: 313.
199. Flagg GL, Silberman H, Takamoto SK, Berne TV. The influence of hepatitis B infection on the outcome of renal allotransplantation. Transplant Proc 1987; 19: 2.155.
200. Sengar DP, Couture RA, Lazarovits AI, Jindal SL. Long-term patient and renal allograft survival in HBsAg infection: a recent update. Transplant Proc 1989; 21 (2): 3.358-3.359.
201. Pol S, Dubois F, Mattlinger B, Carnot F, Legendre C, Brechot C et al. Abscence of hepatitis delta virus infection chronic hemodialysis and kidney transplant patients in France. Transplantation 1992; 54 (6): 1.096-1.097.
202. Lutwick LI, Sywassink JM, Corry RJ. The transmission of hepatitis B by renal transplantation. Clin Nephrol 1983; 19: 317.
203. Chan TM, Lok AS, Cheng IK, Chan RT. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993; Mar 104 (3): 862-868.
204. Akpolat T, Arik N, Arinsoy T, Sungur C, Bakkaloglu M, Erkan I et al. High prevalence of antibodies to hepatitis C virus among renal transplant recipients: correlation with chronic liver dysfunction. Nephron 1993; 64 (1): 163-164.
205. Greco M, Cristiano K, Leozappa G, Rapicetta M, Rizzoni G. Hepatitis C infection in children and adolescents on haemodyalisis and after renal transplant. Pediatr Nephrol 1993; 7: 424-427.
206. Valeri M, Pisani, De Paolis P, Piazza A, Torlone N, Utzeri G et al. Hepatitis C virus infection in kidney transplant recipients. Transplant Proc. 1993; 25 (3): 2.284-2.285.
207. Conlon PJ, Walshe JJ, Smyth EG, McNamara EB, Donohoe J, Carmody M. Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland. Ir J Med Sci 1993; 162 (4): 145-147.
208. Roth D, Fernández JA, Babischkin S, De Mattos A, Buck BE, Quan S et al. Detection of hepatitis C virus infection among cadaver program donors: evidence for low transmission of disease. Ann Intern Med 1992; 117(6): 470-475.
209. Fristche C, Brandes JC, Delaney SR, Gallagher-Lepak S, Menitove JE, Rich L et al. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993; 55 (6): 1.283-1.287.
210. Aeder M, Shield C, Tegmeier G et al. Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation. Tranplant Proc 1993; 25: 1.469-1.471.
211. Pereira BJG, Milford E, Kirkman R et al. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454-460.
212. Wright T, Coombs C, Kim M et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 773-779.
213. Baltimore-Boston Collaborative Group. Human Immunodeficiency virus infection in hemodyalisis patients. Arch Intern Med 1988; 148: 617.
214. Feduska NJ, Perkins HA, Melzer J, Amand WJC, Vincenti F, Tomlanovich S et al. Observation relating to the incidence of the acquired immunodeficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients. Transplant Proc 1987; 19: 2.161.
215. Kerman RH, Flechner SM, Van Buren CT, Lorber MI, Dawson G, Falk L et al. Investigation of human T-lymphotropic virus III serology in a renal transplant population. Transplant Proc 1987; 19: 2.173.
216. Briner V, Zimerli W, Cathomas G, Landmann J, Thiel G. HIV infection caused by kidney transplant: case report and review of 18 published cases. Schweiz Med Wochenschr 1989; 119 (30): 1.046-1.052.
217. Pérez G, Ortiz-Interian C, Bourgoignie JJ, Lee H, do Medina M, Allain JP et al. HIV-1 and HTLV-I infection in renal transplant recipients. J Acquir Immune Defic Syndr 1990; 3(1): 35-40.
218. Ribot S, Eslami HH. HIV infection in kidney transplant recipients. N J Med 1992; 89 (8): 579-599.
219. Schwarz A, Offerman G, Keller F, Bennhold I, L'age-Stehr J, Krause PH et al. The effet of cyclosporine on the progression of human immunodeficiency virus type A infection transmitted by transplantation data on four cases and review of the literature. Tansplantation 1993; 55 (1): 95-103.
220. Neumayer HH, Fassbinder W, Kresse S, Wagner K. Human T-lymphotropic virus III antibody screening in kidney transplant recipients and patients receiving maintenance hemodyalisis. Transplant Proc 1987; 19: 2.169.
221. Bowen PA, Lobel SA, Caruna RJ. Transmission of Human Immunodeficiency Virus (HIV) by transplantation. Clynical aspects and time course analysis of viral antigenemia and antibody production. Ann Intern Med 1988; 108: 46.
222. Prompt CA, Reis MM, Grillo FM, Kopstein J, Kraemer E, Manfro RC et al. Transmission of AIDS virus at renal transplantation. Lancet 1985; 2: 672.
223. Oliveira DBG, Winearls CG, Cohen J, Ind PW, Williams G. Severe immunosuppression in a renal transplant recipient with HTLV-III antibodies. Transplantation 1986; 1: 260.
224. L'Age-Stehr J, Schwarz A, Offermann G, Langmaack H, Bennhold I, Niedrig M et al. HTLV-III infections in kidney transplant recipients. Lancet 1985; 2: 1.361.
225. Kumar P, Pearson JJE, Martin DH, Leech SH, Buisseret PD, Bezbak HC et al. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106: 244.
226. Carbone LG, Cohen DJ, Hardy MA, Benvenisty AI, Scully BE, Appel GB. Determination of acquired immunodeficiency syndrome (AIDS) after renal transplantation. Am J Kidney Dis 1988; 11 (5): 387-392.
227. Dummer JS, Erb S, Breining MK, Ho M, Rinaldo CR Jr., Gupta P. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation 1989; 47 (1): 134-140.
228. Baum KF. Immunosuppression in HIV-infected transplant recipients. Rev Infect Dis 1991; 13: 537-547.
229. Rudlinger R, Smith IW, Bunney MH, Hunter JAA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115: 681.
230. Van der Leest RJ, Zachow KR, Ostrow RS, Bender M, Pass F, Faras AJ. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol 1987; 123: 354.
231. Dyall-Smith D, Trowell H, Dyall-Smith ML. Benign human papillomavirus infection in renal transplant recipients. Int J Dermatol 1991; 30: 785-789.
232. Montagne R, Hannart V, Rosnet D, Casola M, Shillinger F. Human papillomavirus and intraepithelial cervical cancer after renal transplantation. A propos of 2 observations. Nephrologie 1992; 13 (2): 167-170.
233. Sassolas B, Bourbigot B, Plantin P, Le Roy JP. Guillet G. Papillomavirus type II skin infection associated with spinocellular carcinoma in a kidney transplant recipient. Presse Med 1991; 20: 563-564.
234. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated hum an papillomavirus types in cutaneous cancer from renal transplant recipients. J Clin Microbiol 1995; 33 (3): 690-695.
235. Soler C, Chardonnet Y, Allibert P, Euvrard S, Schmitt D, Mandrand B. Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. J Invest Dermatol 1993; 101 (3): 286-291.
236. Soler C, Chardonnet Y, Euvrard S, Chignol MC, Thivolet J. Evaluation of human papillomavirus type 5 on frozen sections of multiple lesions from transplant recipients with in situ hybridization and non isotopic probes. Dermatology 1992; 184 (4): 248-253.
237. Lecatsas G. Papillomavirus in urine in pregnancy and following renal transplantation. Prog Clin Biol Res 1983; 105; 143-148.
238. Gentile G, Formelli G, Orsoni G, Rinaldi AM, Busacchi P. Immunossupression and human genital papillomavirus infection. Eur J Gynaecol Oncol 1991; 12: 79-81.
239. Lewenstohn-Fuchs I, Wester D, Bistoletti P, Elfgren K, Ohlman S, Dillner J et al. Serological responses to human papillomavirus type 16 antigens in women before and after renal transplantation. J Med Virol 1993; 40 (3): 188-192.
240. Beckmann AM, Shah KV, Mounts SP. Genetic heterogeneity of de human papovaviruses BK and JC. J Med Virol 1985; 15 (3): 239-250.
241. Andrews CA, Daniel RW, Shah KV. Serologic studies of papovavirus infections in pregnant women and renal transplant recipients. Prog Clin Biol Res 1983; 105: 133-141.
242. Andrews CA, Shah KV, Daniel RW, Hirsch MS, Rubin RH. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 1988; 158(1): 176-181.
243. Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL. Human Polyomavirus infections with JC virus and BK virus in renal transplant patiens. Ann Intern Med 1980; 92: 373.
244. Us D, Ustacelebi S. Detection of BK virus activation in renal and bone marrow transplantation patients using serological and virological methods. Mikrobiol Bul 1992; 26 (3): 214-223.
245. Holt DA, Sinnot JT, Oehler RL, Bradley EA. BK virus. Infect Control Hosp Epidemiol 1992; 13 (12): 738-741.
246. Blohme I, Nyberg G, Jeansson S, Svalander C. Adenovirus infection in a renal transplant patient. Transplant Proc 1992; 24: 295.
247. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microb Rev 1992; 5 (3): 262-274.
248. Meyerowitz RL, Stalder H, Oxman MN. Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med 1975; 59: 591.
249. Stalder H, Hierholzer JC, Oxman MN. New human adenovirus (candidate adenovirus typo 35) causing fatal disseminated infection in a renal transplant recipient. J Clin Microbiol 1977; 6: 257.
250. Zahradnik JM, Spencer MJ, Porter DD. Adenovirus infection in the immunocompromised patient. Am J Med 1980; 68: 725.
251. Ito M, Hirabayashi N, Uno Y, Nakayama A, Asai J. Necrotizing tubulointerstitial nephritis associated with adenovirus infection. Hum Pathol 1991; 22: 1.221-1.231.
252. Yagisawa T, Nakada T, Takahasi K, Toma H, Ota K, Yaguchi H. Acute hemorrhagic cystitis caused by adenovirus after kidney transplantation. Urol Int 1995; 54 (3): 142-146.
253. Norris SH, Butler TC, Glass N, Tran R. Fatal hepatic necrosis caused by disseminated type 5 adenovirus infection in a renal transplant patient. Am J Nephrol 1989; 9 (2): 101-105.
254. Schirm J, Manson WL, Schroder FP, Tegzee AM, Van der Avoort HG, de Jong JC. An adenovirus epidemic in patients with kidney transplantation. Ned Tijdschr Geneeskd 1991; 135: 1.310-1.314.
255. Uemura N, Ozawa K, Tani K, Nishikawa M, Inoue S, Nagao T et al. Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient. Eur J Haematol 1995; 54 (1): 68-69.
256. Peigue-Lafeuille H, Henquell C, Chambon M, Gazuy N, De Champs C, Cluzel R. Nosocomial rotavirus infections in adult renal transplant recipients. J Hosp Infect 1991; 18: 67-70.
257. Ljungman P, Andersson J, Aschan J, Barkholt L, Ehrnst A, Johansson M et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17 (2): 244-247.
258. Apalsch Am, Green M, Ledesma-Medina J, Nour B, Wald ER. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20 (2): 394-399.
259. Kumar SS, Ventura AK, Vander-Werf B. Influenza vaccination in renal transplant recipients. JAMA 1978; 239: 840.
260. Pabico RC, Douglas G, Betts RF, McKenna BA, Freeman RB. Antibody response to influenza vaccination in renal transplant patients. Correlation with allograft function. Ann Intern Med 1976; 85: 431.